Market Report on China’s Biopharmaceutical Industry, 2008-2010

Nov. 4, 2008 - PRLog -- Summary of the report
China's biopharmaceutical industry has great potential although it only accounted for 8.6% of the total sales of pharmaceutical industry in 2007.

The market of China's biopharmaceutical industry is gradually expanding duo to such favorable factors as China's rapid economic growth, people's higher income, increasing understanding and demand of biopharmaceutical. Biopharmaceutical industry plays a more important role in national economy and draws more attention from investors.

With the improvement of health care system and people's rising awareness of disease treatment, more non-conservative treatment methods are used in clinical treatment, which has promoted the development of blood products. Currently, blood products frequently used in clinical treatment include over 20 types, belonging to such 3 sub-catalogues as human serum albumin, immunoglobulin and coagulation factors.

The demand of charged vaccine has increased dramatically with the rising consumption power and health awareness of people so that charged vaccine market is expanding rapidly. Charged vaccine as a supplement to free vaccine program has promoted the rapid growth of domestic vaccine market, the external diagnostic reagent is becoming familiar with people owing to people's deeper understanding of catalogues and curative effect of biological drugs. Nowadays genetic drugs and antibody drugs are replacing the chemical drugs which have many side effects to cure the cancer patients, and this will bring more opportunities for cancer patients to survive.

The import and export volume of China's biopharmaceutical products was 377 million dollars in 2007, increased by 48% as compared with last year. The import volume reached 336 million dollars, increased by 51% as compared with 2006, and the export volume was 41 million dollars .The growth rate of export volume in 2007 had declined from the level of 58% in 2006 to 26% in 2007. Although the export of China's biopharmaceutical industry constantly kept a high growth rate, the volume is very small as compared with the import volume. As mentioned above, the export volume was only 41 million dollars in 2007 whereas the import volume added up to 336 million USD. This sharp contrast indicated that China's biopharmaceutical products accounted for a very low market ratio in international market.

Table of Contents
1 Overview on China's biopharmaceutical industry
1.1 General situation of the development of the biopharmaceutical industry
1.1.1 Definitions of the biopharmaceutical industry
1.1.2 Features of the biopharmaceutical industry
1.1.3 Catalogues of the biopharmaceutical industry
1.1.4 Current situation and trends of the global biopharmaceutical industry
1.1.5 Current situation of China's biopharmaceutical industry
1.2 Forecast and analysis of the supply
1.2.1 Supply volume analysis
1.2.2 Supply structure analysis
1.2.3 Supply forecasts from 2008 to 2010
1.3 Forecast and analysis of the demand
1.3.1 Demand volume analysis
1.3.2 Demand structure analysis
1.3.3 Demand forecasts from 2008 to 2010
1.4 Forecast and analysis of the import and export  
1.4.1 Analysis of the import and export of China's biopharmaceutical industry
1.4.2 Forecast on the import and export of the biopharmaceutical industry
1.5 Analysis of prices and the balance between supply and demand
1.5.1 Forecast and analysis of the balance between supply and demand   
1.5.2 Forecast and analysis of price changes

2 Forecast and analysis of competitions in China's biopharmaceutical industry   
2.1 Analysis and forecast of features of competitions
2.1.1 Concentration of company is rising
2.1.2 Industry regulation is reinforced
2.1.3 Analysis of competitions between foreign giants and Chinese companies
2.2 Forecast and analysis of the competition structures in biopharmaceutical industry
2.2.1 Prospective entrepreneurs
2.2.2 Threats of substitutes
2.2.3 Buyer's bargaining skills
2.2.4 Seller's bargaining skills
2.2.5 Competitions in current competitors
2.3 Forecast and analysis of companies' merges and acquisitions
2.4 Analysis and forecast of technology development

3 Analysis of sub-sectors of China's biopharmaceutical industry
3.1 blood products
3.1.1 Overview on blood product markets   
3.1.2 Analysis and forecast of blood product markets
3.2 Vaccine
3.2.1 General situation of the vaccine market   
3.2.2 Forecast and analysis of the vaccine market
3.3 Diagnostic reagent
3.4 Genetic recombination drugs

4 Regional analysis of China's biopharmaceutical industry
4.1 Comprehensive analysis and forecast of regional distributions
4.1.1 Analysis and forecast of regional distribution scales
4.1.2 Analysis and forecast of regional distribution benefits
4.2 Shandong Province
4.2.1 Overview on the biopharmaceutical industry in Shandong Province
4.2.2 Analysis of the operations
4.2.3 Forecast on development trends
4.3 Zhejiang Province
4.4 Jiangsu Province
4.5 Shanghai

5 Analysis of China's biopharmaceutical companies   
5.1 Analysis of characteristics
5.1.1 Analysis of scale features
5.1.2 Characteristics of corporate ownerships
5.1.3 Regional analysis of corporations
5.2 Comparisons in listed companies
5.2.1 Overall rank analysis
5.2.2 Profitability analysis
5.2.3 Management capacity analysis
5.2.4 Solvency analysis
5.2.5 Development analysis
5.3 Hualan Biological Engineering Inc.
5.3.1 Profiles   
5.3.2 Research& development capacity
5.3.3 Operations
5.3.4 Analysis of the company's major business  
5.3.5 Forecast on the company's development plan and prospect
5.4 Shanghai Kehua Bioengineering Co., Ltd

6 Risk analysis of the development of China’s biopharmaceutical industry
6.1 Environment risk analysis
6.1.1 Analysis of influence from international environment
6.1.2 Analysis of influence from macro economy
6.1.3 Analysis for influence from exchange rate variation
6.2 Policy risk analysis
6.2.1 Analysis of influence from industry policies
6.2.2 Analysis of influence from environment-protection policies
6.2.3 Health care reform
6.3 Market risk analysis
6.3.1 Risk from supply and demand
6.3.2 Price risks
6.3.3 Competition analysis

7 analysis of investment and development of China’s biopharmaceutical industry from 2008 to 2010
7.1 Analysis of investment opportunities in the biopharmaceutical industry
7.1.1 Analysis of overall investment opportunities
7.1.2 Analysis of investment opportunities in sub-sectors
7.1.3 Analysis of regional investment opportunities
7.2 Analysis of investment opportunities in relevant industries   
7.2.1 Analysis of investment opportunities in medicine business
7.2.2 Analysis for investment opportunities in medical devices
7.3 Recommendations on investment and development

Selected Charts
Chart  The world's top 20 biopharmaceutical corporations in 2007    
Chart  Market scales of China's biopharmaceutical industry from 2003 to 2007
Chart  Forecast on market sizes of China's biopharmaceutical industry, 2008-2012
Chart Relevant policies issued by Chinese government for supporting the biopharmaceutical industry
Chart  Regulations of Chinese government on biopharmaceutical industry
Chart  List of China's blood products manufacturers passed GMP certification in 2007
Chart  The major cases about annexation and technology transfer of the world vaccine industry from 2005 to 2007
Chart  Analysis of market scales of the global major gene drugs, 2004-2010
Chart  The operations of biopharmaceutical industry in Shandong Province
Chart  Analysis of import and export volumes of China's biopharmaceutical industry, 2004-2007
Chart  The trends of China's albumin products' price  
Chart  The analysis of the global vaccine market share

Companies mentioned
Hualan Biological Engineering Inc.
Shanghai Kehua Bioengineering Co., Ltd

# # #

We are devoted to research China’s industries and markets. We publish about 80 reports in Chinese. In late 2007, we entered English report market, and keep our consistent enthusiasm in improve the quality of our products.